
Reginald A. Renwick
Examiner (ID: 15419, Phone: (571)270-1913 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3715, 3714 |
| Total Applications | 1008 |
| Issued Applications | 720 |
| Pending Applications | 71 |
| Abandoned Applications | 234 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19111214
[patent_doc_number] => 20240122964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => COMPOSITIONS AND METHODS TO REDUCE INFILTRATION OF PATHOGENIC AND ANTHROPOGENIC ENVIRONMENTAL FACTORS INTO THE BRAIN
[patent_app_type] => utility
[patent_app_number] => 18/541398
[patent_app_country] => US
[patent_app_date] => 2023-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18541398
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/541398 | COMPOSITIONS AND METHODS TO REDUCE INFILTRATION OF PATHOGENIC AND ANTHROPOGENIC ENVIRONMENTAL FACTORS INTO THE BRAIN | Dec 14, 2023 | Pending |
Array
(
[id] => 19142243
[patent_doc_number] => 20240141073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => METHOD FOR MANUFACTURING CELLULOSE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 18/494749
[patent_app_country] => US
[patent_app_date] => 2023-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18494749
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/494749 | METHOD FOR MANUFACTURING CELLULOSE DERIVATIVE | Oct 24, 2023 | Pending |
Array
(
[id] => 20320094
[patent_doc_number] => 20250332182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-30
[patent_title] => Galactooligosaccharides for improving immune response
[patent_app_type] => utility
[patent_app_number] => 18/557304
[patent_app_country] => US
[patent_app_date] => 2023-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557304
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557304 | Galactooligosaccharides for improving immune response | May 2, 2023 | Pending |
Array
(
[id] => 18496110
[patent_doc_number] => 20230218654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING
HYPERGLYCEMIA IN TYPE-2 DIABETES
[patent_app_type] => utility
[patent_app_number] => 18/181016
[patent_app_country] => US
[patent_app_date] => 2023-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181016
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/181016 | COMPOSITIONS AND METHODS FOR TREATING HYPERGLYCEMIA IN TYPE-2 DIABETES | Mar 8, 2023 | Pending |
Array
(
[id] => 18449576
[patent_doc_number] => 20230190852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => COMPOSITIONS AND METHODS FOR JOINT HEALTH
[patent_app_type] => utility
[patent_app_number] => 18/113370
[patent_app_country] => US
[patent_app_date] => 2023-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18113370
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/113370 | COMPOSITIONS AND METHODS FOR JOINT HEALTH | Feb 22, 2023 | Pending |
Array
(
[id] => 18535214
[patent_doc_number] => 20230240295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHOD OF AND A COMPOSITION FOR PROTECTING PLANTS AGAINST PLANT PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 18/084399
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18084399
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/084399 | METHOD OF AND A COMPOSITION FOR PROTECTING PLANTS AGAINST PLANT PATHOGENS | Dec 18, 2022 | Abandoned |
Array
(
[id] => 18294205
[patent_doc_number] => 20230103891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => DRUG-LOADED NANOPARTICLES FOR HEPATIC ARTERY CHEMOEMBOLIZATION AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/074561
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18074561
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/074561 | DRUG-LOADED NANOPARTICLES FOR HEPATIC ARTERY CHEMOEMBOLIZATION AND PREPARATION METHOD THEREOF | Dec 4, 2022 | Abandoned |
Array
(
[id] => 18391694
[patent_doc_number] => 20230159912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => COMPOSITIONS AND METHODS FOR NUCLEIC ACID NORMALIZATION
[patent_app_type] => utility
[patent_app_number] => 17/993150
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17993150
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/993150 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID NORMALIZATION | Nov 22, 2022 | Pending |
Array
(
[id] => 18349294
[patent_doc_number] => 20230137405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => COSMETIC COMPOSITIONS COMPRISING HIGH AMOUNTS OF HYDROXYPROPYL TETRAHYDROPYRANTRIOL
[patent_app_type] => utility
[patent_app_number] => 18/050799
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050799
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050799 | COSMETIC COMPOSITIONS COMPRISING HIGH AMOUNTS OF HYDROXYPROPYL TETRAHYDROPYRANTRIOL | Oct 27, 2022 | Pending |
Array
(
[id] => 18339171
[patent_doc_number] => 20230131120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS FOR BODY WEIGHT CONTROL USING THIOLATED CHITOSANS
[patent_app_type] => utility
[patent_app_number] => 17/971753
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/971753 | METHODS FOR BODY WEIGHT CONTROL USING THIOLATED CHITOSANS | Oct 23, 2022 | Abandoned |
Array
(
[id] => 18497697
[patent_doc_number] => 20230220372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => USE OF MIXTURES OF POLYVINYLPYRROLIDONE AND AMMONIUM SULFATE IN THE ISOLATION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/961255
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17961255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/961255 | USE OF MIXTURES OF POLYVINYLPYRROLIDONE AND AMMONIUM SULFATE IN THE ISOLATION OF NUCLEIC ACIDS | Oct 5, 2022 | Pending |
Array
(
[id] => 18311339
[patent_doc_number] => 20230115239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => BIOCOMPATIBLE SCAFFOLD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/960972
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17960972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/960972 | BIOCOMPATIBLE SCAFFOLD AND USE THEREOF | Oct 5, 2022 | Pending |
Array
(
[id] => 18453236
[patent_doc_number] => 20230194516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHOD FOR IMMOBILIZING NUCLEIC ACID COMPOUND, REAGENT KIT, AND SENSOR
[patent_app_type] => utility
[patent_app_number] => 17/930412
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930412 | METHOD FOR IMMOBILIZING NUCLEIC ACID COMPOUND, REAGENT KIT, AND SENSOR | Sep 6, 2022 | Pending |
Array
(
[id] => 18269449
[patent_doc_number] => 20230090691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => COMPOSITIONS AND METHODS FOR PROMOTING AND/OR MAINTAINING VAGINOVULVAL AND PERIANAL TISSUE VITALITY AND TISSUE HEALTH
[patent_app_type] => utility
[patent_app_number] => 17/900606
[patent_app_country] => US
[patent_app_date] => 2022-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17900606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/900606 | COMPOSITIONS AND METHODS FOR PROMOTING AND/OR MAINTAINING VAGINOVULVAL AND PERIANAL TISSUE VITALITY AND TISSUE HEALTH | Aug 30, 2022 | Pending |
Array
(
[id] => 18107976
[patent_doc_number] => 20230000856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => NOVEL USES OF CRENOLANIB
[patent_app_type] => utility
[patent_app_number] => 17/897861
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17897861
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/897861 | NOVEL USES OF CRENOLANIB | Aug 28, 2022 | Abandoned |
Array
(
[id] => 18612244
[patent_doc_number] => 20230278976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => Synthesis Of Beta-Glycolipid Compounds
[patent_app_type] => utility
[patent_app_number] => 17/858059
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/858059 | Synthesis Of Beta-Glycolipid Compounds | Jul 4, 2022 | Abandoned |
Array
(
[id] => 17928350
[patent_doc_number] => 20220323475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => COMBINATION THERAPY FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 17/844691
[patent_app_country] => US
[patent_app_date] => 2022-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/844691 | COMBINATION THERAPY FOR CANCER | Jun 19, 2022 | Abandoned |
Array
(
[id] => 19316778
[patent_doc_number] => 20240238318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => L-FUCOSE AND ANTI-ANDROGEN RECEPTOR THERAPY FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/559204
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559204
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559204 | L-FUCOSE AND ANTI-ANDROGEN RECEPTOR THERAPY FOR TREATMENT OF CANCER | May 5, 2022 | Pending |
Array
(
[id] => 18266752
[patent_doc_number] => 20230087994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => TARGETED BIFUNCTIONAL DEGRADERS
[patent_app_type] => utility
[patent_app_number] => 17/654990
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 447
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17654990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/654990 | TARGETED BIFUNCTIONAL DEGRADERS | Mar 14, 2022 | Abandoned |
Array
(
[id] => 19345193
[patent_doc_number] => 20240254156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => NOVEL ISOFLAVONE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/564287
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564287
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564287 | NOVEL ISOFLAVONE COMPOUND | Mar 13, 2022 | Pending |